| #38 |
Jonathan Schultz |
Thermo Fisher |
1 |
| #38 |
Adam Charles Talbot |
Forma Therapeutics |
1 |
| #38 |
John J. Schirra |
RTX (Raytheon) |
1 |
| #38 |
Robert Crelin |
Kmc Music |
1 |
| #38 |
Monika Brandrup |
— |
1 |
| #38 |
Shannon Smith |
Yale University |
1 |
| #38 |
Peter Glazer |
Yale University |
1 |
| #38 |
James G. Moore |
Amerityre |
1 |
| #38 |
Andrew J. Phillips |
C4 Therapeutics |
1 |
| #38 |
David Maass |
Dow-United Technologies Composite Products |
1 |
| #38 |
Michael Mennone |
Bose |
1 |
| #38 |
Jose Costa |
Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud |
1 |
| #38 |
Jeffrey R. Amroziak |
Charge Fusion Technologies |
1 |
| #38 |
David Lawcock |
AT&T |
1 |
| #38 |
Richard D. Gresham |
Tyco Healthcare Group Lp |
1 |
| #38 |
James Andrew Whitney |
Gilead Sciences |
1 |
| #38 |
Bartolomeo Palmieri |
RTX (Raytheon) |
1 |
| #38 |
Victoria F. Albert |
Hartford Fire Insurance |
1 |
| #38 |
Robert A. Levine |
Abbott |
1 |
| #38 |
Ralph Robert Corradi |
Covidien Lp |
1 |
| #38 |
Michael R. Robbins |
Sikorsky Aircraft |
1 |
| #38 |
Luca Rastelli |
Curagen |
1 |
| #38 |
Peter Noel Burrow |
— |
1 |
| #38 |
Astrid Clarke |
Gilead Sciences |
1 |
| #38 |
Karen C. Paolella |
— |
1 |
| #38 |
Adam Roth |
Yale University |
1 |
| #38 |
Jennifer Tran |
Neurogen |
1 |
| #38 |
Paul Maxted |
Butterfly Network |
1 |
| #38 |
John R. Nobile |
Pitney Bowes |
1 |
| #38 |
Shally Hsueh-Wen Wang |
454 Life Sciences |
1 |